<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="119429">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02025270</url>
  </required_header>
  <id_info>
    <org_study_id>NCT010066099</org_study_id>
    <secondary_id>Azhar23052011</secondary_id>
    <nct_id>NCT02025270</nct_id>
  </id_info>
  <brief_title>MSCs For Treatment of Azoospermic Patients</brief_title>
  <official_title>Using of Bone Marrow Derived Mesenchymal Stem Cells For Treatment of Azoospermic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Al-Azhar University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Al-Azhar University</source>
  <oversight_info>
    <authority>Egypt: Ministry of Health and Population</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, we performed autologous BMDMSC transplantation to the testis of Azoospermic
      patients in a trial to enhance and activate the spermatogonial stem cells of the testis and
      aiming to produce motile sperm.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Bone marrow aspirated and stem cells were isolated, cultured and characterized using flow
      cytometer. Stem cells prepared according to GMP regulations then injected into rete testis
      using special syringe. Patients follow up will carried out for a year , three month
      interval. FSH, testosterone, testicular size as well as sexual potency will assessed every
      three months.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">October 2014</completion_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>All Cases Improvement</measure>
    <time_frame>One Year (12-Month)</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Hormonal Assessment: Serum (Testosterone , FSH, LH and Prolactin). Testicular Size. Sexual Potencey.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>All Cases Fertility Improvement</measure>
    <time_frame>One Year (12-Month)</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Hormonal Assessment: Serum (Testosterone , FSH, LH and Prolactin) Testicular size and Sexual Potencey.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Male Infertility</condition>
  <arm_group>
    <arm_group_label>Laboratory and Clinical</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>60 ml of Bone marrow will aspirated for stem cells isolation and preparation. 5 ml of stem cells prepared according to GMP rules injected into rete testis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Stem Cells</intervention_name>
    <description>60 ml of bone marrow will aspirated and used for stem cells isolation. Then stem cells will cultured using autologous serum, characterized and prepared using GMP rules and finally injected into rete testis.</description>
    <arm_group_label>Laboratory and Clinical</arm_group_label>
    <other_name>Stem Cell Dose</other_name>
    <other_name>3-5 Million Autologous MSCs Injected into rete testis.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All Non obstructive Azoospermic Patients.

          -  Azoospermic Patients due to Administration of Chemo/Radiotherapy.

        Exclusion Criteria:

          -  Patients with Testicular Cancer.

          -  Patients with Complete Deletion of Chromosome Y AZF (a,b,c) Regions.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Taimour M Khalifa, MD Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Al-Azhar University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sayed Bakry, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Al-Azhar University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hala Gabr, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wael Abu Elkhier, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Miltary Academy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Saad Moneer, MSc</last_name>
    <role>Study Chair</role>
    <affiliation>Al-Azhar University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Taimour M Khalifa, MD</last_name>
    <phone>+201222115517</phone>
    <email>taimour.khalifa@azher.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sayed Bakry, PhD</last_name>
    <phone>+201006609978</phone>
    <email>sayed.bakry@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Al Azhar University , School of Medicine</name>
      <address>
        <city>Nasr City</city>
        <state>Cairo</state>
        <zip>11884</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sayed Bakry, PhD</last_name>
      <phone>+201006609978</phone>
      <email>sayed.bakry@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Taimour Khalifa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sayed Bakry, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hala Gabr, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wael Abu El Khier, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 12, 2014</lastchanged_date>
  <firstreceived_date>December 13, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Al-Azhar University</investigator_affiliation>
    <investigator_full_name>Sayed Bakry</investigator_full_name>
    <investigator_title>Associate Professor , Consultant of Separation and Culturing of Stem Cells</investigator_title>
  </responsible_party>
  <keyword>Azoospermia, Spermatogonial Arrest, Maturation Arrest.</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Male</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
